drugset / Trial / NCT00219700
Ibuprofen-PC Compared With Ibuprofen in a GI Safety Trial
Phase 2
Completed
125 enrolled
PLx Pharma
National Institutes of Health (NIH) · collabTexas Higher Education Coordinating Board · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
To determine the safety and efficacy of 3 x 800 mg/day IBU-PC assessed by endoscopy and incidence of adverse events
Timeline
- Start
- 2005-01
- Primary completion
- 2005-11
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ibuprofen-PC | Unknown | 800 mg | — |